These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 19047174)

  • 1. Requirement for estrogen receptor alpha in a mouse model for human papillomavirus-associated cervical cancer.
    Chung SH; Wiedmeyer K; Shai A; Korach KS; Lambert PF
    Cancer Res; 2008 Dec; 68(23):9928-34. PubMed ID: 19047174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Requirement of estrogen receptor alpha DNA-binding domain for HPV oncogene-induced cervical carcinogenesis in mice.
    Son J; Park JW; Lambert PF; Chung SH
    Carcinogenesis; 2014 Feb; 35(2):489-96. PubMed ID: 24148821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus E7 oncoprotein overrides the tumor suppressor activity of p21Cip1 in cervical carcinogenesis.
    Shin MK; Balsitis S; Brake T; Lambert PF
    Cancer Res; 2009 Jul; 69(14):5656-63. PubMed ID: 19584294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of cervical cancer in women and in a human papillomavirus-transgenic mouse model: identification of minichromosome maintenance protein 7 as an informative biomarker for human cervical cancer.
    Brake T; Connor JP; Petereit DG; Lambert PF
    Cancer Res; 2003 Dec; 63(23):8173-80. PubMed ID: 14678972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Requirement for stromal estrogen receptor alpha in cervical neoplasia.
    Chung SH; Shin MK; Korach KS; Lambert PF
    Horm Cancer; 2013 Feb; 4(1):50-9. PubMed ID: 23065599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human papillomavirus E6 oncogene dysregulates the cell cycle and contributes to cervical carcinogenesis through two independent activities.
    Shai A; Brake T; Somoza C; Lambert PF
    Cancer Res; 2007 Feb; 67(4):1626-35. PubMed ID: 17308103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical roles for non-pRb targets of human papillomavirus type 16 E7 in cervical carcinogenesis.
    Balsitis S; Dick F; Dyson N; Lambert PF
    Cancer Res; 2006 Oct; 66(19):9393-400. PubMed ID: 17018593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial oestrogen receptor α is dispensable for the development of oestrogen-induced cervical neoplastic diseases.
    Son J; Park Y; Chung SH
    J Pathol; 2018 Jun; 245(2):147-152. PubMed ID: 29532467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the epidermal growth factor receptor by erlotinib prevents immortalization of human cervical cells by Human Papillomavirus type 16.
    Woodworth CD; Diefendorf LP; Jette DF; Mohammed A; Moses MA; Searleman SA; Stevens DA; Wilton KM; Mondal S
    Virology; 2011 Dec; 421(1):19-27. PubMed ID: 21982220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virus transcript levels and cell growth rates after naturally occurring HPV16 integration events in basal cervical keratinocytes.
    Scarpini CG; Groves IJ; Pett MR; Ward D; Coleman N
    J Pathol; 2014 Jul; 233(3):281-93. PubMed ID: 24752734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical cancers require the continuous expression of the human papillomavirus type 16 E7 oncoprotein even in the presence of the viral E6 oncoprotein.
    Jabbar SF; Park S; Schweizer J; Berard-Bergery M; Pitot HC; Lee D; Lambert PF
    Cancer Res; 2012 Aug; 72(16):4008-16. PubMed ID: 22700879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line.
    Kim YW; Chaturvedi PK; Chun SN; Lee YG; Ahn WS
    Oncol Rep; 2015 Apr; 33(4):1675-82. PubMed ID: 25633640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ERa-36 instead of ERa mediates the stimulatory effects of estrogen on the expression of viral oncogenes HPV E6/E7 and the malignant phenotypes in cervical cancer cells.
    Zhang X; Zhang A; Zhang X; Hu S; Bao Z; Zhang Y; Jiang X; He H; Zhang TC
    Virus Res; 2021 Dec; 306():198602. PubMed ID: 34662680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoplastic change of squamo-columnar junction in uterine cervix and vaginal epithelium by exogenous estrogen in hpv-18 URR E6/E7 transgenic mice.
    Park JS; Rhyu JW; Kim CJ; Kim HS; Lee SY; Kwon YI; Namkoong SE; Sin HS; Um SJ
    Gynecol Oncol; 2003 Jun; 89(3):360-8. PubMed ID: 12798696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus oncogenes reprogram the cervical cancer microenvironment independently of and synergistically with estrogen.
    Spurgeon ME; den Boon JA; Horswill M; Barthakur S; Forouzan O; Rader JS; Beebe DJ; Roopra A; Ahlquist P; Lambert PF
    Proc Natl Acad Sci U S A; 2017 Oct; 114(43):E9076-E9085. PubMed ID: 29073104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of Dependence on Continued Expression of the Human Papillomavirus 16 E7 Oncogene in Cervical Cancers and Precancerous Lesions Arising in Fanconi Anemia Pathway-Deficient Mice.
    Park S; Park JW; Pitot HC; Lambert PF
    mBio; 2016 May; 7(3):. PubMed ID: 27190216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E7 oncoprotein from human papillomavirus 16 alters claudins expression and the sealing of epithelial tight junctions.
    Uc PY; Miranda J; Raya-Sandino A; Alarcón L; Roldán ML; Ocadiz-Delgado R; Cortés-Malagón EM; Chávez-Munguía B; Ramírez G; Asomoza R; Shoshani L; Gariglio P; González-Mariscal L
    Int J Oncol; 2020 Oct; 57(4):905-924. PubMed ID: 32945372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in HPV16/18-positive cervical cancer cells.
    Ding W; Hu Z; Zhu D; Jiang X; Yu L; Wang X; Zhang C; Wang L; Ji T; Li K; He D; Xia X; Liu D; Zhou J; Ma D; Wang H
    Clin Cancer Res; 2014 Dec; 20(24):6495-503. PubMed ID: 25336692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of human papillomavirus type 16 E7 protein on the growth of cervical carcinoma cells and immuno-escape through the TGF-beta1 signaling pathway.
    Xu Q; Wang S; Xi L; Wu S; Chen G; Zhao Y; Wu Y; Ma D
    Gynecol Oncol; 2006 Apr; 101(1):132-9. PubMed ID: 16269171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence of high-grade cervical dysplasia and cervical cancer requires the continuous expression of the human papillomavirus type 16 E7 oncogene.
    Jabbar SF; Abrams L; Glick A; Lambert PF
    Cancer Res; 2009 May; 69(10):4407-14. PubMed ID: 19435895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.